Stockholm, August 30, 2013 –
From September 1, 2013 Attana will again resume direct sales operations in
Europe and North America. This change will entail that all sales of Attana
systems and services will be handled solely by Attana representatives on these
Attana is fully committed to offer customers around the world with proprietary tools and competences to enhance the success rate and efficiency in the complex process of developing pharmaceuticals.
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.